Sign In
Buy CVALF
$1.55
-0.0200 (-1.27%)
At Close: Jun 02, 2026
Covalon Technologies Ltd. (COV:CA) Q4 2025 Earnings Call Transcript
11:02am, Thursday, 11'th Dec 2025
Covalon Technologies Ltd. (COV:CA) Q4 2025 Earnings Call Transcript
Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
07:00am, Thursday, 11'th Dec 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourt
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
07:00am, Thursday, 04'th Dec 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fisc
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength
05:30pm, Wednesday, 19'th Nov 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment o
Covalon Declares First Ever Special Cash Dividend
07:00am, Tuesday, 21'st Oct 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Boar
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025
07:00am, Monday, 20'th Oct 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company improving lives through innovative wou
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety an
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
07:00am, Thursday, 25'th Sep 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation in the As
Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair
05:00pm, Tuesday, 23'rd Sep 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting
07:00am, Thursday, 18'th Sep 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the As
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of re
Covalon Technologies Ltd. (CVALF) Q3 2025 Earnings Call Transcript
10:31am, Thursday, 21'st Aug 2025
Covalon Technologies Ltd. (OTCQX:CVALF) Q3 2025 Earnings Conference Call August 21, 2025 8:30 AM ET Company Participants Brent Ashton - CEO & Director Saleha Assadzada - Corporate Participant Operator
Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance
07:00am, Thursday, 21'st Aug 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 third
Covalon Technologies Ltd. Achieves DTC Eligibility in the United States
07:00am, Wednesday, 20'th Aug 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that its commo
CORRECTING and REPLACING Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results
09:35am, Thursday, 14'th Aug 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--The date in the first paragraph should read: Thursday, August 21, 2025 (instead of Wednesday, August 21, 2025). The updated release reads: COVALON ANNOUNCES CONF
